tiprankstipranks
Advertisement
Advertisement
West Pharmaceutical announces new $1B share repurchase program
PremiumThe FlyWest Pharmaceutical announces new $1B share repurchase program
2M ago
West Pharmaceutical price target lowered to $300 from $370 at BofA
Premium
The Fly
West Pharmaceutical price target lowered to $300 from $370 at BofA
2M ago
West Pharmaceutical price target lowered to $340 from $355 at UBS
Premium
The Fly
West Pharmaceutical price target lowered to $340 from $355 at UBS
2M ago
West Pharmaceutical: Strong Quarterly Beat and Confident 2026 Outlook Support Buy Rating Despite GLP‑1 Concerns
PremiumRatingsWest Pharmaceutical: Strong Quarterly Beat and Confident 2026 Outlook Support Buy Rating Despite GLP‑1 Concerns
2M ago
West Pharmaceutical Services Posts Solid Q4 and 2025 Results
Premium
Company Announcements
West Pharmaceutical Services Posts Solid Q4 and 2025 Results
2M ago
West Pharmaceutical sees Q1 adjusted EPS $1.65-$1.70, consensus $1.65
Premium
The Fly
West Pharmaceutical sees Q1 adjusted EPS $1.65-$1.70, consensus $1.65
2M ago
West Pharmaceutical price target lowered to $320 from $390 at Evercore ISI
PremiumThe FlyWest Pharmaceutical price target lowered to $320 from $390 at Evercore ISI
2M ago
West Pharmaceutical Services: GLP-1 Dependency, Emerging Oral-Formulation Risks, and Insufficient Diversification Justify Hold Rating
Premium
Ratings
West Pharmaceutical Services: GLP-1 Dependency, Emerging Oral-Formulation Risks, and Insufficient Diversification Justify Hold Rating
3M ago
West Pharmaceutical: SmartDose Divestiture Clarifies Strategy and Enhances Margin Outlook, Supporting Buy Rating
Premium
Ratings
West Pharmaceutical: SmartDose Divestiture Clarifies Strategy and Enhances Margin Outlook, Supporting Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100